John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Oxford Industries
OXM
$544M
| $1.67M | ﹤0.01% |
+18,445
| New | +$1.63M |
|
|
WPRT
1427
Westport Fuel Systems
WPRT
$34.8M
| $1.67M | ﹤0.01% |
105,473
-59,440
| -36% | -$1.06M |
|
|
CITE
1428
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $1.67M | ﹤0.01% |
+166,666
| New | +$1.66M |
|
|
CCMP
1429
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.66M | ﹤0.01% |
8,971
-38,677
| -81% | -$7.13M |
|
1430
BioXcel Therapeutics
BTAI
$23.2M
| $1.66M | ﹤0.01% |
4,967
+2,914
| +142% | +$845K |
|
1431
Univest Financial
UVSP
$1.15B
| $1.66M | ﹤0.01% |
62,031
+24,181
| +64% | +$711K |
|
1432
V2X
VVX
$2.43B
| $1.65M | ﹤0.01% |
46,067
+38,167
| +483% | +$1.63M |
|
1433
Luxfer Holdings
LXFR
$459M
| $1.64M | ﹤0.01% |
97,853
+19,378
| +25% | +$343K |
|
|
TPC
1434
Tutor Perini Cor
TPC
$4.64B
| $1.63M | ﹤0.01% |
151,322
+79,033
| +109% | +$886K |
|
|
INFN
1435
DELISTED
Infinera Corporation Common Stock
INFN
| $1.63M | ﹤0.01% |
+187,540
| New | +$1.61M |
|
1436
Babcock & Wilcox
BW
$1.18B
| $1.63M | ﹤0.01% |
199,117
-199,219
| -50% | -$1.55M |
|
1437
Intercontinental Exchange
ICE
$90.9B
| $1.63M | ﹤0.01% |
12,303
-687,315
| -98% | -$88.8M |
|
1438
Lazard
LAZ
$4.2B
| $1.61M | ﹤0.01% |
+46,823
| New | +$1.81M |
|
1439
Pixelworks
PXLW
$42.6M
| $1.61M | ﹤0.01% |
45,320
-30,455
| -40% | -$1.21M |
|
|
VG
1440
DELISTED
Vonage Holdings Corporation
VG
| $1.61M | ﹤0.01% |
79,500
-247,201
| -76% | -$5.06M |
|
1441
Innospec
IOSP
$2.3B
| $1.61M | ﹤0.01% |
17,373
-14,894
| -46% | -$1.41M |
|
|
EXTN
1442
DELISTED
Exterran Corporation
EXTN
| $1.61M | ﹤0.01% |
+258,647
| New | +$1.38M |
|
|
TIXT
1443
DELISTED
TELUS International
TIXT
| $1.6M | ﹤0.01% |
+64,900
| New | +$1.72M |
|
|
TVRD
1444
Tvardi Therapeutics
TVRD
$24.1M
| $1.6M | ﹤0.01% |
3,668
+1,260
| +52% | +$517K |
|
1445
Astrana Health
ASTH
$1.82B
| $1.6M | ﹤0.01% |
+32,943
| New | +$1.7M |
|
1446
Passage Bio
PASG
$14.6M
| $1.59M | ﹤0.01% |
25,662
+4,232
| +20% | +$349K |
|
|
CDR
1447
DELISTED
Cedar Realty Trust, Inc
CDR
| $1.59M | ﹤0.01% |
57,575
+24,135
| +72% | +$606K |
|
|
NPKI
1448
NPK International
NPKI
$1.11B
| $1.59M | ﹤0.01% |
434,530
+26,494
| +6% | +$98.4K |
|
|
AHRT
1449
AH Realty Trust
AHRT
$506M
| $1.59M | ﹤0.01% |
108,638
-17,971
| -14% | -$259K |
|
1450
Sally Beauty Holdings
SBH
$1.54B
| $1.59M | ﹤0.01% |
+101,486
| New | +$1.76M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.